Alligator Bioscience AB
F:7AL
Alligator Bioscience AB
F:7AL
Price:
0.3276
EUR
-5.24%
Market Closed
Market Cap:
€251m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alligator Bioscience AB
F:7AL
|
SE |
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
C
|
Cantargia AB
F:7V3
|
SE |
|
Largo Inc
F:LR8
|
CA |
|
S
|
Surteco Group SE
DUS:SUR
|
DE |
|
AVITA Medical Inc
F:51KA
|
US |
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
F:Y2O
|
GR |
Wall St Price Targets
7AL Price Targets Summary
Alligator Bioscience AB
Alligator Bioscience AB
Wall Street analysts forecast 7AL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 7AL is 2.3643 EUR with a low forecast of 2.3411 EUR and a high forecast of 2.4338 EUR.
Lowest Forecast
Price Target
2.3411
EUR
615% Upside
Average Forecast
Price Target
2.3643
EUR
622% Upside
Highest Forecast
Price Target
2.4338
EUR
643% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7AL's stock price target?
Price Target
2.3643
EUR
2.3643
EUR
According to Wall Street analysts, the average 1-year price target for 7AL is 2.3643 EUR with a low forecast of 2.3411 EUR and a high forecast of 2.4338 EUR.
What is the Revenue forecast for Alligator Bioscience AB?
Projected CAGR
95%
95%
Over the last 10 years, the compound annual growth rate for Revenue has been -47%. The projected CAGR for the next 2 years is 95%.
